Life sciences
-
How UK life science can win the global race
Investing more in UK life sciences will mean benefits for patients, industry and the UK, says Professor Sir John Bell, author of the Life Sciences Industrial Strategy Report.
-
UK biotech pipeline progressing at pace
The UK's impressive preclinical and clinical pipeline shows the strength and capability of the UK biotech ecosystem in proding fantastic science that attracts talent and funding from across the globe.
-
Research and regulation – securing a win-win for patients across Europe
Patients across Europe currently benefit from the close collaboration between medical researchers who investigate, develop and test new treatments on an EU-wide basis.
-
Investing in life sciences pays off for everyone
UK life sciences is getting a huge boost from government. Greg Clark, Secretary of State for Business, Energy and Industrial Strategy, explains why this benefits us all.
-
Brexit’s impact on MedTech: regulation and trade
From single-use products like wound care dressings, to multi-use technology like pacemakers: the likelihood is we will all need medtech at some stage during our life. It's a sector underpinned by strict regulation.
-
Get on top of export regulation in the life sciences
What can exporters in the life sciences do to overcome the myriad of complex rules and regulations in the sector internationally?
Business & Industry